IPNews® – The Federal Circuit on Tuesday ruled that a lower court was wrong to find Medtronic Inc. did not infringe two patents for a heart implant device held by a company that licensed the patents to a Boston Scientific Corp. unit.
The appeals court remanded the matter for further proceedings, saying the district court